ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.5303
Delayed Data
As of Apr 24
 -0.0061 / -1.14%
Today’s Change
0.43
Today|||52-Week Range
1.45
-27.36%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.54
Today’s open0.54
Day’s range0.52 - 0.55
Volume430,683
Average volume (3 months)923,176
Market cap$48.4M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...+0.04+2.76%
AEZSAEterna Zentaris Inc-0.01-1.57%
--Protea Biosciences G...0.000.00%
ABACAoxin Tianli Group I...+0.06+3.61%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$9.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers